|
|
Volumn 34, Issue 3, 2002, Pages 948-949
|
|
Effectiveness of aggressive prophylatic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
CYTOMEGALOVIRUS ANTIBODY;
GANCICLOVIR;
OKT 3;
STEROID;
TACROLIMUS;
VIRUS DNA;
BIOPSY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DNA DETERMINATION;
ENTEROPATHY;
EPSTEIN BARR VIRUS;
FOLLOW UP;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE TRANSPLANTATION;
KIDNEY FUNCTION;
LIVER TRANSPLANTATION;
LYMPHOMA;
MORBIDITY;
PATIENT MONITORING;
PHYSICAL EXAMINATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RADIODIAGNOSIS;
RETROSPECTIVE STUDY;
SYMPTOM;
VIREMIA;
VIRUS CULTURE;
VIRUS INFECTION;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS INFECTIONS;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
EPSTEIN-BARR VIRUS INFECTIONS;
GANCICLOVIR;
HUMANS;
INTESTINES;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0036262206
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02710-0 Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (6)
|
